Posts Tagged Speech therapy

Let’s get moving! Increase your activity level safely with uniquely designed mobility products

Do you have concerns with your balance, posture, or stamina when you are walking? Are you looking to increase your activity level but have difficulty moving safely and confidently? Join this informational webinar to watch representatives from the U-Step Neuro Walker and Urban Poling show you how their innovative walking devices are designed to prevent falls, increase mobility and function, and improve participation in life’s activities. Topics covered during the webinar include: The individual profiles best suited for the U-Step Neuro Walker and Urban Poling Real life examples of individuals who have benefited from the U-Step Neuro Walker and Urban Poling How to acquire the U-Step Neuro Walker and Urban Poling, including information about Medicare/insurance coverage This is a corporate sponsored webinar hosted by LSVT Global, Inc. Intended Audience: Individuals with Parkinson’s disease and their family members and caregivers, Healthcare professionals

Continue Reading

Expand your Clinical Reach: How to Apply LSVT BIG® Beyond Parkinson’s Disease

Did you know that LSVT BIG may be applied to individuals with neurological conditions other than Parkinson’s disease (PD)? Join LSVT BIG Faculty and special guest panelists as they discuss research and clinical reports on the effectiveness of LSVT BIG for populations beyond PD, with a special emphasis on stroke and pediatric populations. Learn how to determine if LSVT BIG may be right for select clients on YOUR caseload. Intended Audience: Physical and Occupational Therapy Professionals and Students

Continue Reading

Tired of your device not understanding your speech? Sign up for Project Euphonia!

LSVT Global has partnered with Google on an exciting project called Project Euphonia to help improve automatic speech recognition software for people with speech impairments. These speech impairments may make using devices like Siri, Alexa, or speech-to-text frustrating. To do this, we need samples of disordered speech to train the system. LSVT Global is recruiting people with speech disorders to help!

Continue Reading

LSVT Global Team Member Spotlight! Jessica Galgano Ph.D., CCC-SLP

Learn more about our LSVT Global Team member Jessica Galgano, Ph.D., CCC-SLP. Jessica is an integral part of our team serving as LSVT LOUD faculty, LOUD for KIDS faculty and our LSVT LOUD clinical expert all while running her own successful private practice. Thank you, Jessica, for all you do for LSVT Global!

Continue Reading

Got a Challenging Case? How LSVT LOUD® and LSVT BIG® Can Help Complex Clients

Do you serve clients with complex conditions and are wondering if and how LSVT treatments can be helpful for them? Join LSVT LOUD and LSVT BIG Experts for a discussion on treating individuals with challenging diagnoses such as advanced or atypical PD, other neurological conditions, and pediatric cases. Learn about characteristics specific to more complex populations as well as treatment strategies and adaptations available within the LSVT protocols.   Intended Audience: Allied Health Professionals

Continue Reading

Everything you need to know about LSVT LOUD® and LSVT BIG®: A guide for people with PD and those who support them!

Do you help support and care for someone who is receiving LSVT LOUD or LSVT BIG?  You can be a key part of optimizing their success in achieving and maintaining a louder voice and bigger movements in daily life. Tune in for a general overview of the treatments, recommendations on how to help facilitate homework and carryover exercises outside of the treatment sessions, and suggestions for motivation and encouragement.   Intended Audience: Individuals with PD and their caregivers

Continue Reading

Expand your Clinical Reach: How to Apply LSVT Treatments Beyond Parkinson’s Disease

While LSVT LOUD® and LSVT BIG® were researched and developed for individuals with Parkinson’s disease (PD), these treatment approaches have also successfully been applied to adults and children with other neurological conditions. Join LSVT LOUD and LSVT BIG Expert Clinicians as they discuss research studies and clinical cases on LSVT treatments applied to individuals with a diagnosis other than PD and how the clinical assessment can help determine if LSVT LOUD or LSVT BIG may be appropriate for select clients on your caseload. Intended audience: Allied health professionals

Continue Reading

The Acoustic Voice Quality Index (AVQI) in People with Parkinson’s Disease Before and After Intensive Voice and Articulation Therapies: Secondary Outcome of a Randomized Controlled Trial

This study presents the first randomized controlled trial (RCT) examining the effects of two speech treatment approaches, LSVT LOUD and LSVT ARTIC, on voice quality in individuals with Parkinson’s disease (PD). Both treatments were identical in how intensive they were, but LSVT LOUD targeted healthy loudness, whereas LSVT ARTIC focused on articulation. Additionally, an untreated group of individuals with PD also participated in the study, and a group of 20 individuals without PD were included to examine differences in voice quality at pre-treatment.

Continue Reading

LSVT Global Team Member Spotlight! Gary Boyle

Learn more about our LSVT Global Team member Gary Boyle who is one of our LSVT LOUD Volunteer Ambassadors. Gary is an inspiration to all of those around him with his compassion, positivity and eloquent words to share with faculty, fellow volunteers and LSVT clinicians in training. We are so fortunate to have you, Gary, as a part of our team. Thank you for the inspiration you give to us all!

Continue Reading

Immediate and long-term effects of speech treatment targets and intensive dosage on Parkinson’s disease dysphonia and the speech motor network: Randomized controlled trial

This study looked at speech and brain changes in individuals with Parkinson’s disease following two speech treatment approaches, matched for intensity of dosage (16, 1-hour individual sessions in one month) but differing on treatment target, loudness (LSVT LOUD) or articulation (LSVT ARTIC). A group of untreated individuals with Parkinson’s disease were also studied as a comparison group. All participants were evaluated at baseline, post-treatment (one month after baseline), and seven months after baseline to help identify both short-term and long-term changes.  

Continue Reading